SCHEMBL4773735

SCHEMBL4773735

NC(=O)CCCN(CCC(CCc1ccccc1)c1ccccc1)C(N)=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
HDAC1 Q13547 2/20 0.40
HDAC3 O15379 1/20 0.40
MAPK1 P28482 1/20 0.40
ADRA1A P35348 1/20 0.40
HDAC4 P56524 1/20 0.40
SLC6A3 Q01959 1/20 0.40
HDAC7 Q8WUI4 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC10 Q969S8 1/20 0.40
HDAC11 Q96DB2 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
HDAC9 Q9UKV0 1/20 0.40
HDAC5 Q9UQL6 1/20 0.40
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
PKM P14618 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4772104 0.95 GRIK1 (0.40) ALOX5SMN1; SMN2HDAC1HDAC3MAPK1
SCHEMBL4558971 0.83 SMN1; SMN2 (0.47) SMN1; SMN2HDAC1HDAC3MAPK1ADRA1A
SCHEMBL4561028 0.82 SMN1; SMN2 (0.49) SMN1; SMN2HDAC1HDAC3MAPK1ADRA1A
SCHEMBL7151687 0.79 HDAC3 (0.47) SMN1; SMN2HDAC1HDAC3MAPK1ADRA1A
SCHEMBL1952933 0.77 ALOX5 (0.56) ALOX5SMN1; SMN2HDAC1HDAC3MAPK1
SCHEMBL1954648 0.75 SIGMAR1 (0.53) ALOX5SMN1; SMN2HDAC1HDAC3MAPK1
SCHEMBL12329847 0.75 HRH1 (0.44) ALOX5SMN1; SMN2MAPK1SLC6A3CYP1A2
SCHEMBL4560570 0.74 F2 (0.53) SMN1; SMN2CYP1A2CYP2D6PKMNPSR1
SCHEMBL16933744 0.74 SIGMAR1 (0.56) ALOX5SMN1; SMN2HDAC1HDAC3MAPK1
SCHEMBL1954766 0.74 SIGMAR1 (0.56) ALOX5SMN1; SMN2HDAC1HDAC3MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1874283-A2 USE OF NOVEL COMPOUNDS FOR IBD TREATMENT Ferring BV (NL) 2008-01-09 EP claimed
WO-2006116399-A2 USE OF NOVEL COMPOUNDS FOR IBD TREATMENT FERRING B.V. (NL) 2006-11-02 WO claimed
EP-1675822-A2 AMIDE OR THIOAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF PAIN Cara Therapeutics, Inc. (US) 2006-07-05 EP claimed
WO-2005037798-A2 AMIDE OR THIOMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF PAIN CARA THERAPEUTICS, INC (US) 2005-04-28 WO claimed
EP-1874283-A2 USE OF NOVEL COMPOUNDS FOR IBD TREATMENT Ferring BV (NL) 2008-01-09 EP disclosed
WO-2006116399-A2 USE OF NOVEL COMPOUNDS FOR IBD TREATMENT FERRING B.V. (NL) 2006-11-02 WO disclosed
EP-1675822-A2 AMIDE OR THIOAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF PAIN Cara Therapeutics, Inc. (US) 2006-07-05 EP disclosed
WO-2005037798-A2 AMIDE OR THIOMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF PAIN CARA THERAPEUTICS, INC (US) 2005-04-28 WO disclosed